Pay vs Performance Disclosure - USD ($)
|
12 Months Ended |
Jan. 28, 2024 |
Jan. 29, 2023 |
Jan. 30, 2022 |
Jan. 31, 2021 |
Pay vs Performance Disclosure |
|
|
|
|
Pay vs Performance Disclosure, Table |
Pay Versus Performance As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are providing the following pay versus performance table to illustrate the relationship between executive compensation actually paid and certain of the Company’s financial performance measures. For information regarding the Company’s pay-for-performance philosophy and how the Company aligns executive compensation with its performance, refer to the Compensation Discussion and Analysis section above. | | | | | | | | | | | | | | | Value of Initial Fixed $100
Investment Based On: | | | | | | | Fiscal
Year
(a) | | | Summary
Compensation
Table (“SCT”)
Total for Principal
Executive Officer
(“PEO”)
(b)1 | | | Compensation
Actually Paid
(“CAP”) to PEO
(c)2 | | | Average SCT
Total for
non-PEO
NEOs
(d)1 | | | Average CAP
to non-PEO
NEOs
(e)2 | | | Total
Shareholder
Return
(“TSR”)
(f)3 | | | Peer
Group
TSR
(g)4 | | | Net Income
(Loss)7
(in thousands)
(h)5 | | | Net Sales7
(in thousands)
(i)6 | 2023 | | | $35,186,195 | | | $32,600,316 | | | $3,821,594 | | | $1,288,780 | | | $73.10 | | | $145.07 | | | $39,580 | | | $11,147,720 | 2022 | | | $2,481,735 | | | $(2,550,628) | | | $896,717 | | | $(984,632) | | | $173.18 | | | $76.96 | | | $49,899 | | | $10,119,000 | 2021 | | | $12,450,338 | | | $(85,796,398) | | | $2,242,415 | | | $(32,080,908) | | | $165.79 | | | $84.41 | | | $(75,207) | | | $8,967,407 | 2020 | | | $3,027,525 | | | $181,666,232 | | | $1,274,216 | | | $65,584,171 | | | $384.08 | | | $168.83 | | | $(92,486) | | | $7,146,264 |
(1)
| Included in column (b) are the total compensation amounts reported in the Summary Compensation Table for Mr. Singh, our PEO for each of the fiscal years presented. Included in column (d) are the average total compensation amounts for non-PEO NEOs reported in the Summary Compensation Table. Our non-PEO NEOs for each of the fiscal years presented consist of Mr. Marte, Mr. Mehta, and Ms. Helfrick. Our non-PEO NEOs for Fiscal Year 2023 also include Ms. Bowman and Mr. Morant. |
(2)
| Included in columns (c) and (e) are CAP and average CAP to the PEO and the non-PEO NEOs, respectively, for each of the fiscal years presented. To calculate CAP and average CAP, amounts in columns (b) and (d) are adjusted in accordance with Item 402(v) of Regulation S-K requirements and are presented in the tables below. These amounts do not reflect the actual amount of compensation earned by or paid to the PEO and our non-PEO NEOs for each of the fiscal years presented. |
PEO SCT to CAP Reconciliation | | | | Fiscal Year | | | | 2023 | | | 2022 | | | 2021 | | | 2020 | SCT Total | | | $35,186,195 | | | $2,481,735 | | | $12,450,338 | | | $3,027,525 | Less value of Stock Awards reported in SCT | | | (31,048,358) | | | — | | | (10,106,250) | | | — | Plus year-end fair value of outstanding and unvested equity awards granted in the year | | | 31,209,397 | | | — | | | 5,493,750 | | | — | (Less) plus year over year change in fair value of outstanding and unvested equity awards granted in prior years | | | — | | | 854,397 | | | (64,828,925) | | | 140,610,021 | (Less) plus year over year change in fair value of equity awards granted in prior years that vested in the year | | | (2,746,918) | | | (5,886,760) | | | (28,805,311) | | | 38,028,686 | CAP Total | | | $32,600,316 | | | $(2,550,628) | | | $(85,796,398) | | | $181,666,232 |
Average of Non-PEO NEOs SCT to CAP Reconciliation | | | | Fiscal Year | | | | 2023 | | | 2022 | | | 2021 | | | 2020 | SCT Total | | | $3,821,594 | | | $896,717 | | | $2,242,415 | | | $1,274,216 | Less value of Stock Awards reported in SCT | | | (3,284,969) | | | — | | | (1,347,500) | | | — | Plus year-end fair value of outstanding and unvested equity awards granted in the year | | | 1,412,899 | | | — | | | 732,500 | | | — | (Less) plus year over year change in fair value of outstanding and unvested equity awards granted in prior years | | | (61,656) | | | 279,816 | | | (23,338,392) | | | 50,619,617 | (Less) plus year over year change in fair value of equity awards granted in prior years that vested in the year | | | (723,564) | | | (2,161,165) | | | (10,369,931) | | | 13,690,338 | Plus fair value as of vesting date of equity awards granted and vested in the year | | | 173,563 | | | — | | | — | | | — | Less prior year-end fair value for any equity awards forfeited in the year | | | (49,087) | | | — | | | — | | | — | CAP Total | | | $1,288,780 | | | $(984,632) | | | $(32,080,908) | | | $65,584,171 |
(3)
| Based on an initial fixed investment of $100 on January 29, 2021, the last business day of our 2020 fiscal year. |
(4)
| Represents the Dow Jones Internet Commerce Index, which we consider to be our peer group under Regulation S-K Item 201(e), as presented in our 2023 Annual Report. Based on an initial fixed investment of $100 on January 29, 2021, the last business day of our 2020 fiscal year. TSR is weighted according to each peer company’s stock market capitalization at the beginning of each period for which a return is indicated. |
(5)
| Represents our net income (loss) amounts for each of the years presented as reported in the respective annual report on Form 10-K. |
(6)
| We have selected net sales as our most important financial measure (that is not otherwise required to be disclosed in the table) used to link the CAP of our NEOs to company performance for Fiscal Year 2023. |
(7)
| Consistent with the Company’s Annual Report on Form 10-K for Fiscal Year 2023, the Company has updated historical comparative periods to reflect the operations of Chewy Pharmacy KY beginning with the Company’s 2021 Fiscal Year. Any historical comparatives prior to Fiscal Year 2021 are consistent with previously reported financial information. |
|
|
|
|
Company Selected Measure Name |
net sales
|
|
|
|
Named Executive Officers, Footnote |
(1)
| Included in column (b) are the total compensation amounts reported in the Summary Compensation Table for Mr. Singh, our PEO for each of the fiscal years presented. Included in column (d) are the average total compensation amounts for non-PEO NEOs reported in the Summary Compensation Table. Our non-PEO NEOs for each of the fiscal years presented consist of Mr. Marte, Mr. Mehta, and Ms. Helfrick. Our non-PEO NEOs for Fiscal Year 2023 also include Ms. Bowman and Mr. Morant. |
|
|
|
|
Peer Group Issuers, Footnote |
(4)
| Represents the Dow Jones Internet Commerce Index, which we consider to be our peer group under Regulation S-K Item 201(e), as presented in our 2023 Annual Report. Based on an initial fixed investment of $100 on January 29, 2021, the last business day of our 2020 fiscal year. TSR is weighted according to each peer company’s stock market capitalization at the beginning of each period for which a return is indicated. |
|
|
|
|
PEO Total Compensation Amount |
$ 35,186,195
|
$ 2,481,735
|
$ 12,450,338
|
$ 3,027,525
|
PEO Actually Paid Compensation Amount |
$ 32,600,316
|
(2,550,628)
|
(85,796,398)
|
181,666,232
|
Adjustment To PEO Compensation, Footnote |
(2)
| Included in columns (c) and (e) are CAP and average CAP to the PEO and the non-PEO NEOs, respectively, for each of the fiscal years presented. To calculate CAP and average CAP, amounts in columns (b) and (d) are adjusted in accordance with Item 402(v) of Regulation S-K requirements and are presented in the tables below. These amounts do not reflect the actual amount of compensation earned by or paid to the PEO and our non-PEO NEOs for each of the fiscal years presented. |
PEO SCT to CAP Reconciliation | | | | Fiscal Year | | | | 2023 | | | 2022 | | | 2021 | | | 2020 | SCT Total | | | $35,186,195 | | | $2,481,735 | | | $12,450,338 | | | $3,027,525 | Less value of Stock Awards reported in SCT | | | (31,048,358) | | | — | | | (10,106,250) | | | — | Plus year-end fair value of outstanding and unvested equity awards granted in the year | | | 31,209,397 | | | — | | | 5,493,750 | | | — | (Less) plus year over year change in fair value of outstanding and unvested equity awards granted in prior years | | | — | | | 854,397 | | | (64,828,925) | | | 140,610,021 | (Less) plus year over year change in fair value of equity awards granted in prior years that vested in the year | | | (2,746,918) | | | (5,886,760) | | | (28,805,311) | | | 38,028,686 | CAP Total | | | $32,600,316 | | | $(2,550,628) | | | $(85,796,398) | | | $181,666,232 |
|
|
|
|
Non-PEO NEO Average Total Compensation Amount |
$ 3,821,594
|
896,717
|
2,242,415
|
1,274,216
|
Non-PEO NEO Average Compensation Actually Paid Amount |
$ 1,288,780
|
(984,632)
|
(32,080,908)
|
65,584,171
|
Adjustment to Non-PEO NEO Compensation Footnote |
(2)
| Included in columns (c) and (e) are CAP and average CAP to the PEO and the non-PEO NEOs, respectively, for each of the fiscal years presented. To calculate CAP and average CAP, amounts in columns (b) and (d) are adjusted in accordance with Item 402(v) of Regulation S-K requirements and are presented in the tables below. These amounts do not reflect the actual amount of compensation earned by or paid to the PEO and our non-PEO NEOs for each of the fiscal years presented. |
Average of Non-PEO NEOs SCT to CAP Reconciliation | | | | Fiscal Year | | | | 2023 | | | 2022 | | | 2021 | | | 2020 | SCT Total | | | $3,821,594 | | | $896,717 | | | $2,242,415 | | | $1,274,216 | Less value of Stock Awards reported in SCT | | | (3,284,969) | | | — | | | (1,347,500) | | | — | Plus year-end fair value of outstanding and unvested equity awards granted in the year | | | 1,412,899 | | | — | | | 732,500 | | | — | (Less) plus year over year change in fair value of outstanding and unvested equity awards granted in prior years | | | (61,656) | | | 279,816 | | | (23,338,392) | | | 50,619,617 | (Less) plus year over year change in fair value of equity awards granted in prior years that vested in the year | | | (723,564) | | | (2,161,165) | | | (10,369,931) | | | 13,690,338 | Plus fair value as of vesting date of equity awards granted and vested in the year | | | 173,563 | | | — | | | — | | | — | Less prior year-end fair value for any equity awards forfeited in the year | | | (49,087) | | | — | | | — | | | — | CAP Total | | | $1,288,780 | | | $(984,632) | | | $(32,080,908) | | | $65,584,171 |
|
|
|
|
Compensation Actually Paid vs. Total Shareholder Return |
Pay Versus Performance Comparative Disclosure The following graphs illustrate the relationship between CAP as disclosed in the Pay Versus Performance table and (i) the Company’s cumulative TSR, (ii) the peer group’s cumulative TSR, (iii) the Company’s net income (loss), and (iv) net sales. CAP reflects adjusted values to unvested and vested equity awards during the years shown in the table based on year-end stock prices, grant and vesting date fair values, and projected performance modifiers, but does not reflect actual amounts paid out for those awards. CAP generally fluctuates due to stock price volatility and varying levels of projected and actual achievement of performance goals. Compensation Actually Paid versus Company TSR and Peer Group TSR
|
|
|
|
Compensation Actually Paid vs. Net Income |
Pay Versus Performance Comparative Disclosure The following graphs illustrate the relationship between CAP as disclosed in the Pay Versus Performance table and (i) the Company’s cumulative TSR, (ii) the peer group’s cumulative TSR, (iii) the Company’s net income (loss), and (iv) net sales. CAP reflects adjusted values to unvested and vested equity awards during the years shown in the table based on year-end stock prices, grant and vesting date fair values, and projected performance modifiers, but does not reflect actual amounts paid out for those awards. CAP generally fluctuates due to stock price volatility and varying levels of projected and actual achievement of performance goals. Compensation Actually Paid and Net Income (Loss)
|
|
|
|
Compensation Actually Paid vs. Company Selected Measure |
Pay Versus Performance Comparative Disclosure The following graphs illustrate the relationship between CAP as disclosed in the Pay Versus Performance table and (i) the Company’s cumulative TSR, (ii) the peer group’s cumulative TSR, (iii) the Company’s net income (loss), and (iv) net sales. CAP reflects adjusted values to unvested and vested equity awards during the years shown in the table based on year-end stock prices, grant and vesting date fair values, and projected performance modifiers, but does not reflect actual amounts paid out for those awards. CAP generally fluctuates due to stock price volatility and varying levels of projected and actual achievement of performance goals. Compensation Actually Paid and Net Sales
|
|
|
|
Total Shareholder Return Vs Peer Group |
Pay Versus Performance Comparative Disclosure The following graphs illustrate the relationship between CAP as disclosed in the Pay Versus Performance table and (i) the Company’s cumulative TSR, (ii) the peer group’s cumulative TSR, (iii) the Company’s net income (loss), and (iv) net sales. CAP reflects adjusted values to unvested and vested equity awards during the years shown in the table based on year-end stock prices, grant and vesting date fair values, and projected performance modifiers, but does not reflect actual amounts paid out for those awards. CAP generally fluctuates due to stock price volatility and varying levels of projected and actual achievement of performance goals. Compensation Actually Paid versus Company TSR and Peer Group TSR
|
|
|
|
Tabular List, Table |
Tabular List of Performance Measures The following table lists our most important performance measures used by us to link CAP of our NEOs to the Company’s performance for Fiscal Year 2023. For more information, refer to “Named Executive Officer Compensation – Compensation Discussion and Analysis.” We are providing this list in accordance with Item 402(v) of Regulation S-K to provide information on performance measures used by the Compensation Committee to determine NEO compensation, as more fully described in “Named Executive Officer Compensation – Compensation Discussion and Analysis.” Most Important Performance Measures | Net income (loss) | Net sales | Adjusted EBITDA margin(1) | Free cash flow(1) |
(1)
| Adjusted EBITDA margin and free cash flow are non-GAAP financial measures. For a reconciliation of non-GAAP to GAAP financial measures refer to “Reconciliation of Non-GAAP Financial Measures” in Appendix A. |
|
|
|
|
Total Shareholder Return Amount |
$ 73.1
|
173.18
|
165.79
|
384.08
|
Peer Group Total Shareholder Return Amount |
145.07
|
76.96
|
84.41
|
168.83
|
Net Income (Loss) |
$ 39,580,000
|
$ 49,899,000
|
$ (75,207,000)
|
$ (92,486,000)
|
Company Selected Measure Amount |
11,147,720,000
|
10,119,000,000
|
8,967,407,000
|
7,146,264,000
|
PEO Name |
Mr. Singh
|
Mr. Singh
|
Mr. Singh
|
Mr. Singh
|
Measure:: 1 |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Name |
Net income (loss)
|
|
|
|
Measure:: 2 |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Name |
Net sales
|
|
|
|
Measure:: 3 |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Name |
Adjusted EBITDA margin
|
|
|
|
Non-GAAP Measure Description |
(1)
| Adjusted EBITDA margin and free cash flow are non-GAAP financial measures. For a reconciliation of non-GAAP to GAAP financial measures refer to “Reconciliation of Non-GAAP Financial Measures” in Appendix A. |
|
|
|
|
Measure:: 4 |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Name |
Free cash flow
|
|
|
|
Non-GAAP Measure Description |
(1)
| Adjusted EBITDA margin and free cash flow are non-GAAP financial measures. For a reconciliation of non-GAAP to GAAP financial measures refer to “Reconciliation of Non-GAAP Financial Measures” in Appendix A. |
|
|
|
|
PEO | Value of Stock Awards Reported in SCT [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
$ (31,048,358)
|
$ 0
|
$ (10,106,250)
|
$ 0
|
PEO | Year-End Fair Value of Outstanding and Unvested Equity Awards Granted in the Year [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
31,209,397
|
0
|
5,493,750
|
0
|
PEO | Year Over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
0
|
854,397
|
(64,828,925)
|
140,610,021
|
PEO | Year Over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
(2,746,918)
|
(5,886,760)
|
(28,805,311)
|
38,028,686
|
Non-PEO NEO | Value of Stock Awards Reported in SCT [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
(3,284,969)
|
0
|
(1,347,500)
|
0
|
Non-PEO NEO | Year-End Fair Value of Outstanding and Unvested Equity Awards Granted in the Year [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
1,412,899
|
0
|
732,500
|
0
|
Non-PEO NEO | Year Over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
(61,656)
|
279,816
|
(23,338,392)
|
50,619,617
|
Non-PEO NEO | Year Over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
(723,564)
|
(2,161,165)
|
(10,369,931)
|
13,690,338
|
Non-PEO NEO | Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
173,563
|
0
|
0
|
0
|
Non-PEO NEO | Prior Year-End Fair Value for Any Equity Awards Forfeited in the Year [Member] |
|
|
|
|
Pay vs Performance Disclosure |
|
|
|
|
Adjustment to Compensation, Amount |
$ (49,087)
|
$ 0
|
$ 0
|
$ 0
|